vimarsana.com
  1. Home
  2. Live Updates
  3. Webcast Detail - Breaking News

Latest Breaking News On - Webcast detail - Page 2 : vimarsana.com

Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023

RESEARCH TRIANGLE PARK, N.C., July 31, 2023 Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the Company will release its second quarter.

United statesRobert andradeLindsay roccoFennec pharmaceuticals incOregon healthFennec pharmaceuticalsGlobenewswire incElixir health public relationsEuropean commission marketing authorizationScience universityWebcast detailEvent calendarOrphan drug exclusivityPediatric use marketing authorization

Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023 - Fennec Pharmaceuticals (NASDAQ:FENC)

RESEARCH TRIANGLE PARK, N.C., July 31, 2023 (GLOBE NEWSWIRE) Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its

United statesRobert andradeLindsay roccoScience universityFennec pharmaceuticalsFennec pharmaceuticals incElixir health public relationsOregon healthWebcast detailEvent calendarEuropean commission marketing authorizationOrphan drug exclusivityPediatric use marketing authorization

Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023

RESEARCH TRIANGLE PARK, N.C., May 08, 2023 (GLOBE NEWSWIRE) Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty…

United statesNew yorkGabriel friedmanJake edmistonKevin carmichaelLindsay roccoRobert andradeFennec pharmaceuticals to report first quarterFennec pharmaceuticals incNational postScience universityPostmedia network incOregon healthFennec pharmaceuticalsElixir health public relationsReport first quarter

Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023

RESEARCH TRIANGLE PARK, N.C., May 08, 2023 Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2023. | May 8, 2023

United statesRobert andradeLindsay roccoScience universityElixir health public relationsFennec pharmaceuticalsFennec pharmaceuticals incOregon healthWebcast detailEvent calendarOrphan drug designationFennec pharmaceuticals inc stock exchangePress releaseUarter fenc ca31447p1009

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.